C/EBR gamma deregulation results in differentiation arrest in acute myeloid leukemia

M (Meritxell) Alberich Jorda, Bas Wouters, M Balastik, C Shapiro-Koss, H Zhang, A DiRuscio, HS Radomska, AK Ebralidze, G Amabile, M Ye, JY Zhang, I Lowers, Roberto Avellino, A Melnick, ME Figueroa, Peter Valk, Ruud Delwel, DG Tenen

Research output: Contribution to journalArticleAcademicpeer-review

53 Citations (Scopus)


C/EBPs are a family of transcription factors that regulate growth. control and differentiation of various tissues. We found that C/EBP gamma is highly upregulated in a subset of acute Myeloid leukemia (AML) samples characterized by C/EBP alpha hypermethylation/silencing Similarly, C/EBP gamma was upregulated in murine hematopoietic stem/progenitor cells lacking C/EBP alpha, as C/EBP alpha mediates C/EBP gamma suppression. Studies in myeloid cells demonstrated that CEBP6 overexpression blocked neutrophilic differentiation. Further, downregulation of Cebpg in murine Cebpa-deficient stem/progenitor cells or in human CEBPA-silenced AML samples restored granulocytic differentiation hi addition, treatment of these leukemias with demethylating agents restored the. C/EBP alpha-C/EBP gamma balance and upregulated the expression of myeloid differentiation markers. Our-results indicate that C/EBP gamma mediates the myeloid differentiation arrest induced by C/EBP alpha deficiency and that targeting the C/EBP alpha-C/EBP gamma axis rescues neutrophilic differentiation in this unique subset of AMLs.
Original languageEnglish
Pages (from-to)4490-4504
Number of pages15
JournalJournal of Clinical Investigation
Issue number12
Publication statusPublished - 2013

Research programs

  • EMC MM-02-41-03


Dive into the research topics of 'C/EBR gamma deregulation results in differentiation arrest in acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this